These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10841663)

  • 21. Ascorbic acid intake, renal function, and urinary oxalate excretion.
    Conyers RA; Bais R; Rofe AM; Potezny N; Thomas DW
    Aust N Z J Med; 1985 Jun; 15(3):353-5. PubMed ID: 3864430
    [No Abstract]   [Full Text] [Related]  

  • 22. Bariatric surgery, vitamin C, and kidney stones.
    Weiss D
    Cleve Clin J Med; 2010 Dec; 77(12):844; author reply 844. PubMed ID: 21186694
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxalate absorption and endogenous oxalate synthesis from ascorbate in calcium oxalate stone formers and non-stone formers.
    Chai W; Liebman M; Kynast-Gales S; Massey L
    Am J Kidney Dis; 2004 Dec; 44(6):1060-9. PubMed ID: 15558527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of high dose vitamin C on urinary oxalate levels.
    Wandzilak TR; D'Andre SD; Davis PA; Williams HE
    J Urol; 1994 Apr; 151(4):834-7. PubMed ID: 8126804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxalate metabolism and renal calculi.
    Menon M; Mahle CJ
    J Urol; 1982 Jan; 127(1):148-51. PubMed ID: 7035692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary influences on urinary oxalate and risk of kidney stones.
    Massey LK
    Front Biosci; 2003 May; 8():s584-94. PubMed ID: 12700096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascorbic acid administration and urinary oxalate.
    Tsao CS
    Ann Intern Med; 1984 Sep; 101(3):405-6. PubMed ID: 6465722
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose.
    Fairholm L; Saqui O; Baun M; Allard J
    JPEN J Parenter Enteral Nutr; 2005; 29(6):454; author reply 454. PubMed ID: 16224041
    [No Abstract]   [Full Text] [Related]  

  • 30. High intakes of ascorbic acid and urinary oxalate.
    Hughes C; Dutton S; Truswell AS
    J Hum Nutr; 1981 Aug; 35(4):274-80. PubMed ID: 7276555
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers.
    Trinchieri A; Mandressi A; Luongo P; Longo G; Pisani E
    Br J Urol; 1991 Mar; 67(3):230-6. PubMed ID: 2021806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxalate and renal stone formation.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones.
    Huang HS; Ma MC; Chen CF; Chen J
    Urology; 2003 Dec; 62(6):1123-8. PubMed ID: 14665375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion.
    Tiselius HG; Almgård LE
    Eur Urol; 1977; 3(1):41-6. PubMed ID: 556987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible adverse health effects of vitamin C and ascorbic acid.
    Sestili MA
    Semin Oncol; 1983 Sep; 10(3):299-304. PubMed ID: 6364356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Ascorbate acid overdosing: a risk factor for calcium oxalate nephrolithiasis.
    Chalmers A
    J Urol; 1994 Jul; 152(1):171. PubMed ID: 8201656
    [No Abstract]   [Full Text] [Related]  

  • 37. Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers.
    Butz M; Hoffmann H; Kohlbecker G
    Urol Int; 1980; 35(5):309-15. PubMed ID: 7423675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.
    Moyad MA; Combs MA; Crowley DC; Baisley JE; Sharma P; Vrablic AS; Evans M
    Urol Nurs; 2009; 29(2):95-102. PubMed ID: 19507407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms.
    Lin WV; Turin CG; McCormick DW; Haas C; Constantine G
    CEN Case Rep; 2019 Feb; 8(1):67-70. PubMed ID: 30276648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones.
    Massey LK; Sutton RA
    J Am Diet Assoc; 1993 Nov; 93(11):1305-7. PubMed ID: 8227883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.